These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19824807)

  • 1. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.
    Zhao S; Wehner R; Bornhäuser M; Wassmuth R; Bachmann M; Schmitz M
    Stem Cells Dev; 2010 May; 19(5):607-14. PubMed ID: 19824807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effect of mesenchymal stem cells.
    Marti LC; Ribeiro AA; Hamerschlak N
    Einstein (Sao Paulo); 2011 Jun; 9(2):224-8. PubMed ID: 26760821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
    Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
    Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.
    Nasef A; Ashammakhi N; Fouillard L
    Regen Med; 2008 Jul; 3(4):531-46. PubMed ID: 18588475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro.
    Wehner R; Taubert C; Mende T; Gaebler C; de Andrade AV; Bornhäuser M; Werner C; Tonn T; Schäkel K; Bachmann M; Schmitz M
    J Tissue Eng Regen Med; 2013 Nov; 7(11):921-4. PubMed ID: 22610974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.
    Calkoen FG; Brinkman DM; Vervat C; van Ostaijen-Ten Dam MM; Ten Cate R; van Tol MJ; Ball LM
    Cytotherapy; 2013 Mar; 15(3):280-91. PubMed ID: 23312448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
    Saeidi M; Masoud A; Shakiba Y; Hadjati J; Mohyeddin Bonab M; Nicknam MH; Latifpour M; Nikbin B
    Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):37-49. PubMed ID: 23454777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of stem cells.
    Wada N; Gronthos S; Bartold PM
    Periodontol 2000; 2013 Oct; 63(1):198-216. PubMed ID: 23931061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect.
    Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N
    Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
    Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
    Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications.
    Castro-Manrreza ME; Montesinos JJ
    J Immunol Res; 2015; 2015():394917. PubMed ID: 25961059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
    Stagg J; Galipeau J
    Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells: facilitators of successful transplantation?
    English K; French A; Wood KJ
    Cell Stem Cell; 2010 Oct; 7(4):431-42. PubMed ID: 20887949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are mesenchymal stromal cells immune cells?
    Hoogduijn MJ
    Arthritis Res Ther; 2015 Mar; 17(1):88. PubMed ID: 25880839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.